Relating to a Cochrane Systematic Review of the available proof.

Area-wide traffic calming schemes are effective in high-income countries Area-wide traffic calming schemes that discourage through-traffic from using residential roads work at reducing traffic-related injuries in high-income countries and could even reduce deaths . However, more research needs to be carried out to see whether these interventions will work in low – and middle-income countries, relating to a Cochrane Systematic Review of the available proof. Each full season, 1.23 million people die in road traffic incidents. Over the next decade, road deaths are expected to rise especially sharply in low – and middle-income countries.

And Arena Pharmaceuticals, Inc. The transfer establishes Eisai as the advertising authorization holder in charge of regulatory actions in the United States related to the commercialization of BELVIQ, including pharmacovigilance requirements. Arena will continue in its oversight role for the global advancement of BELVIQ while functioning carefully with Eisai for the joint advancement plan in the usa. ‘The NDA transfer furthers our commitment to BELVIQ as we prepare to release in the usa and submit applications for approval throughout the Americas,’ said Lonnel Coats, President and Chief Executive Officer, Eisai Inc. Eisai plans to submit advertising authorization applications based on the NDA to medical authorities through the entire territories in North and South America for which it currently holds commercialization privileges, including Mexico, Canada and Brazil.

Other entries from category "stomatology":

Random entries